Effect of oxytocics on the blood pressure of normotensive Nigerian parturients

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 20, Issue 9, 2007, Pages 703-705

  Jago, A A ^a   Ezechi, O C ^b,d   Achinge, G I ^a   Okunlola, M A ^c  

^a FEDERAL MEDICAL CENTER   (Nigeria)

^b NIGERIAN INSTITUTE OF MEDICAL RESEARCH   (Nigeria)

^c UNIVERSITY OF IBADAN   (Nigeria)

^d NONE   (Nigeria)

Author keywords

Blood pressure; Ergometrine; Nigerian; Oxytocin; Parturient

Indexed keywords

ERGOMETRINE; OXYTOCIN;

ADULT; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; LABOR INDUCTION; LABOR STAGE 3; MAJOR CLINICAL STUDY; MATERNAL CARE; NIGERIA; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PUERPERIUM; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT;

BLOOD PRESSURE; DOUBLE-BLIND METHOD; ERGONOVINE; FEMALE; HUMANS; LABOR STAGE, THIRD; NIGERIA; OXYTOCICS; OXYTOCIN; PARTURITION; POSTPARTUM HEMORRHAGE; PREGNANCY;

EID: 34547877225     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.1080/14767050701500406     Document Type: Article

References (15)

1. Reduction of maternal mortality: A joint WHO/UNFPA/UNICEF/World Bank Statement. Geneva: World Health Organization; 1999. pp 1-13.
2. World Health Organization. Prevention of maternal mortality: Report of a World Health Organization Inter-regional Meeting, 11-15 November, 1985. Geneva: World Health Organization; 1986.
3. Adetoro OO. Primary post-partum haemorrhage at a University Hospital in Nigeria. W Afr J Med 1992;11:172-178.
4. Kwast B. Postpartum haemorrhage: Its contribution to maternal mortality. Midwifery 1991;7:64-67.
5. Harrison KA. Maternal mortality in Nigeria: The real issues. Afr J Reprod Health 1997;1:7-13.
6. Confidential enquiries into maternal mortality for the United Kingdom for 1985-87. London: HMSO; 1991.
7. Petrie JC, O'Brien ET, Littler WA, de Swiet M. Recommendations on blood pressure measurement. BMJ 1986;293:611-615.
8. Ogunbode O, Obisesan K, Ayeni O. Methergine in the management of the third stage of labour: A comparative clinical trial with syntometrine and ergometrine. Curr Ther Res 1979;26:460-465.
9. Browning DJ. Serious side effects of ergometrine and its use in routine obstetric practice. Med J Aust 1974;1:957-959.
10. McDonald S, Prendiville WJ, Elbourne D. Prophylactic syntometrine versus oxytocin for delivery of the placenta. Cochrane Database Syst Rev 2000;(2):CD000201.
11. Bergstrom S. Pre-eclampsia and eclampsia. In: Lawson JB, Harrison KA, Bergstrom S, editors. Maternity care in developing countries. London, UK: RCOG Press; 2001. p 147.
12. World Health Organization. The prevention and management of postpartum haemorrhage. Report of a Technical Working Group, Geneva 3-6 July 1989. Unpublished document WHO/MCH/90.7. Geneva: World Health Organization; 1990.
13. Elbourne DR. Prophylactic syntometrine vs. oxytocin in the third stage of labour. In: Enkin MW, Keirse MJ, Renfrew MJ, Nelson JP, editors. Pregnancy and childbirth module. Oxford: Update Software; 1993 (Cochrane Database Syst Rev Review No. 02999).
14. Mitchell GG, Elbourne DR. The Salford third stage of trial: Oxytocin plus ergometrine versus oxytocin alone in the active management of the third stage of labour. Online J Curr Clin Trials 1993;Doc No 83:[2305 words; 32 paragraphs].
15. Rogers J, Wood J, McCandish R, Ayers S, Truesdale A, Elbourne D. Active versus expectant management of third stage of labour: The Hinchingbrooke randomised controlled trial. Lancet 1998;351:693-699.